Literature DB >> 26037857

Diagnostic Utility of the International HIV Dementia Scale for HIV-Associated Neurocognitive Impairment and Disorder in South Africa.

Karl Goodkin1, David J Hardy1, Dinesh Singh1, Enrique Lopez1.   

Abstract

Studies in sub-Saharan Africa indicate that most HIV seropositive persons have HIV-associated neurocognitive disorder (HAND). HAND diagnosis is facilitated by specific screening. Seventy participants were recruited from an HIV voluntary counseling and testing clinic in Durban, South Africa. The diagnostic utility of the International HIV Dementia Scale (IHDS) was analyzed using a receiver operating characteristic (ROC) model. The ROC analysis comparing any HAND diagnosis (based on two neuropsychological tests) versus no diagnosis was statistically significant, with an optimal cut-off score of 10.5, sensitivity of 69%, and specificity of 74%. Sensitivity of the IHDS was highest for HIV-associated dementia.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 26037857      PMCID: PMC5805556          DOI: 10.1176/appi.neuropsych.13080178

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  26 in total

Review 1.  The use of "overall accuracy" to evaluate the validity of screening or diagnostic tests.

Authors:  Anthony J Alberg; Ji Wan Park; Brant W Hager; Malcolm V Brock; Marie Diener-West
Journal:  J Gen Intern Med       Date:  2004-05       Impact factor: 5.128

2.  Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Council of State and Territorial Epidemiologists; AIDS Program, Center for Infectious Diseases.

Authors: 
Journal:  MMWR Suppl       Date:  1987-08-14

3.  Risk factors for cognitive impairment in HIV-1-infected persons with different risk behaviors.

Authors:  Diana De Ronchi; Irma Faranca; Domenico Berardi; Paolo Scudellari; Marco Borderi; Roberto Manfredi; Laura Fratiglioni
Journal:  Arch Neurol       Date:  2002-05

4.  Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa.

Authors:  N Sacktor; N Nakasujja; R Skolasky; K Robertson; M Wong; S Musisi; A Ronald; E Katabira
Journal:  Neurology       Date:  2006-07-25       Impact factor: 9.910

5.  The International HIV Dementia Scale: a new rapid screening test for HIV dementia.

Authors:  Ned C Sacktor; Matthew Wong; Noeline Nakasujja; Richard L Skolasky; Ola A Selnes; Seggane Musisi; Kevin Robertson; Justin C McArthur; Allan Ronald; Elly Katabira
Journal:  AIDS       Date:  2005-09-02       Impact factor: 4.177

6.  Normative scores for a brief neuropsychological battery for the detection of HIV-associated neurocognitive disorder (HAND) among South Africans.

Authors:  Dinesh Singh; John A Joska; Karl Goodkin; Enrique Lopez; Landon Myer; Robert H Paul; Sally John; Henry Sunpath
Journal:  BMC Res Notes       Date:  2010-01-29

7.  The HIV Dementia Scale: predictive power in mild dementia and HAART.

Authors:  Kara Anne Bottiggi; Jason J Chang; Frederick A Schmitt; Malcolm J Avison; Yunanan Mootoor; Avindra Nath; Joseph R Berger
Journal:  J Neurol Sci       Date:  2007-05-04       Impact factor: 3.181

8.  The prevalence and incidence of neurocognitive impairment in the HAART era.

Authors:  Kevin R Robertson; Marlene Smurzynski; Thomas D Parsons; Kunling Wu; Ronald J Bosch; Julia Wu; Justin C McArthur; Ann C Collier; Scott R Evans; Ron J Ellis
Journal:  AIDS       Date:  2007-09-12       Impact factor: 4.177

9.  Closing gaps in antiretroviral therapy access: human immunodeficiency virus-associated dementia screening instruments for non-physician healthcare workers.

Authors:  Michelle P Kvalsund; Alan Haworth; Daniel L Murman; Ellen Velie; Gretchen L Birbeck
Journal:  Am J Trop Med Hyg       Date:  2009-06       Impact factor: 2.345

10.  Understanding and using sensitivity, specificity and predictive values.

Authors:  Rajul Parikh; Annie Mathai; Shefali Parikh; G Chandra Sekhar; Ravi Thomas
Journal:  Indian J Ophthalmol       Date:  2008 Jan-Feb       Impact factor: 1.848

View more
  12 in total

1.  A Comparison of Five Brief Screening Tools for HIV-Associated Neurocognitive Disorders in the USA and South Africa.

Authors:  J A Joska; J Witten; K G Thomas; C Robertson; M Casson-Crook; H Roosa; J Creighton; J Lyons; J McArthur; N C Sacktor
Journal:  AIDS Behav       Date:  2016-08

Review 2.  End-of-Life Care and Bereavement Issues in Human Immunodeficiency Virus-AIDS.

Authors:  Karl Goodkin; Sindhura Kompella; Steven F Kendell
Journal:  Nurs Clin North Am       Date:  2018-03       Impact factor: 1.208

3.  Interaction Effects between HIV and Aging on Selective Neurocognitive Impairment.

Authors:  Yingying Ding; Haijiang Lin; Weiwei Shen; Qionghai Wu; Meiyang Gao; Na He
Journal:  J Neuroimmune Pharmacol       Date:  2017-05-03       Impact factor: 4.147

4.  Diagnostic utility of the HIV dementia scale and the international HIV dementia scale in screening for HIV-associated neurocognitive disorders among Spanish-speaking adults.

Authors:  Enrique López; Alexander J Steiner; Kimberly Smith; Nicholas S Thaler; David J Hardy; Andrew J Levine; Hussah T Al-Kharafi; Cristina Yamakawa; Karl Goodkin
Journal:  Appl Neuropsychol Adult       Date:  2016-08-15       Impact factor: 2.248

5.  HIV-associated neurocognitive disorder in a KwaZulu-Natal HIV clinic: A prospective study.

Authors:  Jade C Mogambery; Halima Dawood; Douglas Wilson; Anand Moodley
Journal:  South Afr J HIV Med       Date:  2017-09-26       Impact factor: 2.744

Review 6.  Risk Factors and Pathogenesis of HIV-Associated Neurocognitive Disorder: The Role of Host Genetics.

Authors:  Ian Simon Olivier; Ramón Cacabelos; Vinogran Naidoo
Journal:  Int J Mol Sci       Date:  2018-11-14       Impact factor: 5.923

Review 7.  Neurological disorders in HIV in Africa: a review.

Authors:  William P Howlett
Journal:  Afr Health Sci       Date:  2019-06       Impact factor: 0.927

8.  Screening tools for HIV-associated neurocognitive disorders among adults living with HIV in sub-Saharan Africa: A scoping review.

Authors:  Patrick N Mwangala; Charles R Newton; Melanie Abas; Amina Abubakar
Journal:  AAS Open Res       Date:  2019-10-30

Review 9.  Potential pharmacological approaches for the treatment of HIV-1 associated neurocognitive disorders.

Authors:  Amila Omeragic; Olanre Kayode; Md Tozammel Hoque; Reina Bendayan
Journal:  Fluids Barriers CNS       Date:  2020-07-10

10.  Comparison of two screening tests for HIV-Associated Neurocognitive Disorder suspected Japanese patients with respect to cART usage.

Authors:  Kaoru Kami-Onaga; Masao Tateyama; Takeshi Kinjo; Gretchen Parrott; Daisuke Tominaga; Ai Takahashi-Nakazato; Hideta Nakamura; Daisuke Tasato; Kyoko Miyagi; Saori Maeda; Hirotaka Arae; Hitoshi Uehara; Kazuya Miyagi; Shusaku Haranaga; Jiro Fujita
Journal:  PLoS One       Date:  2018-06-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.